Current Management Strategies for Ovarian Cancer
- 30 June 2007
- journal article
- review article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 82 (6) , 751-770
- https://doi.org/10.4065/82.6.751
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Development of an ovarian cancer symptom indexCancer, 2007
- Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancerGynecologic Oncology, 2006
- Relevant molecular markers and targetsGynecologic Oncology, 2006
- Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel–platinumPublished by Elsevier ,2005
- Surgical risk reduction: Prophylactic salpingo-oophorectomy and prophylactic mastectomyAmerican Journal of Obstetrics and Gynecology, 2004
- Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarraysAmerican Journal of Obstetrics and Gynecology, 2004
- Should cancer patients with incurable disease receive parenteral or enteral nutritional support?European Journal Of Cancer, 1998
- Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinomaEuropean Journal Of Cancer, 1994
- Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristineZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patientsJournal of Pain and Symptom Management, 1992